PFF in the Media

2018

10.18.18
Health Data Management: Pulmonary fibrosis organization creates registry for research

10.8.18
We-ha.com: West Hartford Spreads Awareness of Pulmonary Fibrosis, Delamar Turns Fountain Blue

10.5.18
Dallas Medicine Journal: Dallas at the forefront of pulmonary fibrosis research

9.4.18
Chicago Connection with Rebecca Ortiz: Interview with Amy Kozyra

9.3.18
WGN Radio: After Hours with Rick Kogan: The Pulmonary Fibrosis Foundation

8.28.18
ABC33|40: Talk of Alabama - Pulmonary Fibrosis Awareness

7.25.18 
U.S. & World Report News: How Can I Find the Best Pulmonologist?

6.22.18
Media Planet: Putting the Spotlight on Pulmonary Fibrosis with Julie Halston

6.16.18 
San Francisco Business Times: Why investors injected $62 million into a Peninsula biotech targeting a deadly lung disease

5.24.18
HealthNewsReview.orgIn portraying a silver lining to Santa Fe school shooting, news stories mislead public about GoFundMe campaign for victim’s husband

3.30.18
Windy City Gridiron: Spurred by personal tragedy, Jordan Howard seeking to change lives

1.10.18
PF Warrior: Meet Bill Schmidt, the new CEO of the Pulmonary Fibrosis Foundation

2015

8.20.15
790 Talk Now Heidi Harris Show: Interview with Dr. Gregory P. Cosgrove on pulmonary fibrosis

03.26.15
St. Louis Post-Dispatch: Lung transplant saves man who had five years to live

03.13.15
ChicagoTribune.com: Feeling short of breath? It could be something serious*

03.12.15
The Bulletin: Drugs for rare disease out of reach for Bend patient

02.05.15
Daily Southtown: Chicago-based Pulmonary Fibrosis Foundation expands first-of-its-kind care center network; care center network program piloted at University of Chicago

01.05.15
WGNU: PFF Radio Media Tour**

*posted by more than 1,100 online publications including Tribune
**interviews aired on more than 13 broadcast outlets nationwide

2014

11.5.14
WGN: Two new drug options give hope to those suffering pulmonary fibrosis

10.17.14
Pulmonary Hypertension News: 2 IPF drugs get FDA approval; Pulmonary Fibrosis Foundation's Praise

10.17.14 
BioWorld: Air pair Esbriet, Ofev tied for FDA first in IPF; Roche rolling price dice but BI yet to disclose

10.16.14
Tech Times: FDA approval of Roche, Boehringer drugs for idiopathic pulmonary fibrosis is a big step forward

10.16.14
The Science Times: FDA approves two separate drugs for killer lung disease

10.16.14
Uncover Michigan: First two drugs for treatment of fatal lung disease approved by FDA

10.16.14
Capital OTC: FDA approves two drugs (Esbriet, Ofev) for treating fatal lung disease

10.16.14
Delhi Daily News: FDA approves first two drugs for fatal lung disease

10.15.14
San Francisco Business Times: InterMune wins FDA OK for lung-scarring disease drug at center of Roche deal

10.15.14
San Francisco Gate: Roche’s InterMune wins FDA approval for lung disease treatment

10.15.14
The Examiner: The FDA has approved two drugs for a fatal lung disease

10.15.14
The Street: FDA approves competing lung disease drugs from Roche and Boehringer

 

footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >